Sami Diab, MD and Tejas Patil, MD continue their discussion about emerging treatments for HER2+ lung cancer, including data presented from DESTINY-Lung03, liquid biopsies, emerging resistance, and treatment sequencing..
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
